FCER1A rs2155220: What Your Genotype Means
rs2155220 is a common single nucleotide polymorphism located in the promoter-proximal region of the FCER1A gene on chromosome 1. The variant has been investigated for its potential role in modifying the transcriptional responsiveness of FCER1A when high-affinity IgE receptors are engaged on immune effector cells like mast cells and basophils. Overall scientific evidence for its direct trait impacts remains limited, placing it in the category of subtle biological modifiers rather than definitive disease causes.
What each genotype means
Typical baseline IgE expression
You carry two copies of the common C allele in the FCER1A promoter region. In published genetic association studies, this genotype is generally associated with typical baseline levels of high-affinity IgE receptor alpha subunit expression and standard population-average total serum IgE concentrations. The evidence for this variant is limited, and carrying this genotype does not cause or prevent atopic conditions or allergic disease.
Carried by roughly 35% to 40% of individuals of European ancestry and approximately 30% to 35% of individuals of East Asian ancestry.
Intermediate IgE regulation profile
You carry one copy of the T minor allele and one copy of the C reference allele in the FCER1A promoter region. Research suggests an additive statistical association where each copy of the minor allele may subtly modulate transcriptional activity of the FCER1A gene and correlate with modest shifts in circulating total IgE levels. However, clinical evidence remains limited and observational, meaning real-world allergic traits depend heavily on wider genetic and environmental exposures.
Carried by roughly 45% to 50% of people across European and East Asian populations.
Altered IgE regulation profile
You carry two copies of the T minor allele near the promoter of the FCER1A gene. In population cohorts, carrying two copies of this variant has been linked with small statistical variations in FCER1A transcriptional responsiveness and serum IgE levels compared to the common genotype. Because the published evidence is limited and non-diagnostic, this finding should not be interpreted as a medical diagnosis of allergy or immune dysfunction.
Carried by approximately 14% to 18% of individuals of European ancestry and around 16% to 20% of East Asian populations.
Genomic Location and Variant Biology
rs2155220 is a single nucleotide variant mapped within the non-coding promoter-proximal regulatory sequence of the FCER1A gene on human chromosome 1q23. Regulatory variants in gene promoters frequently influence the binding affinity of cellular transcription factors rather than altering the amino acid sequence of the encoded protein. In the context of rs2155220, functional research suggests that nucleotide differences at this locus may modulate how vigorously the FCER1A promoter responds when immune signaling pathways are activated. Because it does not interrupt open reading frames or alter protein structure directly, its biological influence is subtle and largely dependent on cellular stimulation states.
The Role of the FCER1A Gene
The FCER1A gene provides instructions for producing the alpha subunit of the high-affinity IgE receptor, known as FcεRIα. This receptor complex is prominently expressed on the surface of primary allergic effector cells, including basophils, tissue mast cells, and antigen-presenting dendritic cells. FcεRIα acts as the critical docking station that binds circulating immunoglobulin E (IgE) antibodies with exceptionally tight affinity. When an environmental allergen crosslinks two or more IgE molecules bound to FcεRI complexes, it sets off an intracellular signaling cascade leading to degranulation and the rapid release of histamine, proteases, and pro-inflammatory cytokines.
Current Research and Strength of Evidence
Genome-wide association studies and molecular allergy research have robustly established the FCER1A locus as a key genetic determinant of circulating total serum IgE concentrations and allergic sensitization profiles. Within this wider genetic region, researchers have scrutinized rs2155220 to determine whether promoter variations alter receptor expression during IgE receptor crosslinking. Nevertheless, the direct epidemiological evidence connecting rs2155220 itself to distinct clinical diagnoses—such as atopic dermatitis, severe asthma, or clinical anaphylaxis—remains limited. Many observed associations at this locus are driven by broader linkage disequilibrium patterns across the chromosome 1q23 region, meaning rs2155220 represents an exploratory statistical association rather than a verified diagnostic marker.
Population Distribution and Ancestry Differences
rs2155220 is a frequent genetic polymorphism observed across many global populations. Population genetics data indicate that the minor allele frequency (MAF) is approximately 0.38 in individuals of European ancestry and reaches approximately 0.42 in East Asian populations. Because the alternate allele is widespread in hundreds of millions of healthy individuals globally, carrying one or two copies is a normal human variation. The balanced frequency across different geographic ancestries suggests that neither allele confers a severe evolutionary disadvantage, reflecting the multi-factorial and polygenic nature of immune response regulation.
Interpreting Your Results and Clinical Context
Learning your rs2155220 genotype provides insight into normal variation within a central allergy-related signaling gene, but it cannot be used to diagnose allergies or predict immune health. Carrying specific alleles does not mean an individual will develop asthma, rhinitis, or medication hypersensitivity, nor does the presence of an alternate allele guarantee elevated IgE levels. Clinical allergic disease results from an intricate interplay of hundreds of genetic loci alongside environmental factors like allergen exposure and microbiome composition. Genetic data for rs2155220 should be viewed strictly as educational trait information rather than actionable clinical guidance.
How common is this variant?
The minor allele of rs2155220 has an estimated frequency of approximately 0.38 in European populations and approximately 0.42 in East Asian cohorts, making all three genotype combinations common worldwide.
Frequently asked questions
Can rs2155220 tell me if I have a food or seasonal allergy?
No. rs2155220 is a subtle regulatory marker and cannot diagnose any allergy or food sensitivity. True allergic conditions are diagnosed by licensed healthcare providers using clinical history, skin prick testing, or allergen-specific serum IgE laboratory panels.
Does having the T allele mean my IgE levels will be high?
Not necessarily. While the FCER1A genetic locus as a whole is associated with total serum IgE variation in large population studies, the standalone effect size of rs2155220 is small and limited, meaning individual IgE levels are shaped far more by environmental exposures and other polygenic influences.
What does promoter-proximal mean for a genetic variant?
A promoter-proximal variant is located close to the starting site where a gene is copied into RNA. Instead of changing the physical structure of the protein, these variants can subtly influence how strongly or frequently the gene is turned on or off by transcription factors.
Should I change my allergy medications based on this variant?
No, you should never start, stop, or adjust prescription allergy medications based on rs2155220 results. If you have questions about allergy symptoms or medication management, discuss them directly with your physician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2155220?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FCER1A
Variant in the high-affinity IgE receptor alpha subunit associated with total serum IgE concentrations and allergic sensitization.
Regulatory variant in the high-affinity IgE receptor gene FCER1A modulating circulating total IgE concentrations and allergic manifestations.
Variant in the high-affinity IgE receptor alpha subunit locus influencing IgE receptor transcription and susceptibility to atopic allergic sensitization.
Functional FCER1A polymorphism in high linkage disequilibrium with IgE-associated loci that modulates basophil and mast cell IgE receptor expression.
Variant in the high-affinity IgE receptor alpha chain gene strongly associated with regulation of total serum IgE levels and allergic sensitization risk.